SEC Form 4 · accession 0001179110-15-005429
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn Sblendorio
Officer — President & CFO · Director
Period of report
Mar 23, 2015
Accepted (ET)
Mar 25, 2015 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 23, 2015 | S | 34,773 | $30.7801 | D | 102,844 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 plan adopted by Mr. Sblendorio.
- F2Represents the weighted average sales price of the shares sold ranging from a low of $30.75 to a high of $30.97 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.